Iron deficiency markers in patients with advanced heart failure

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00159816%3A_____%2F24%3A00081766" target="_blank" >RIV/00159816:_____/24:00081766 - isvavai.cz</a>

Výsledek na webu

<a href="https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3326" target="_blank" >https://onlinelibrary.wiley.com/doi/full/10.1002/ejhf.3326</a>

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Iron deficiency markers in patients with advanced heart failure

Popis výsledku v původním jazyce

Introduction: Iron deficiency (ID) is a common comorbidity in patients with advanced heart failure (HF). It is associated with decreased performance status, frequent hospitalizations for HF decompensation, and lower quality of life. There is an ongoing debate about the optimal definition of ID and the selection of patients benefiting from iron supplementation. Previously, ID in HF was defined as ferritin &lt; 100 μg/l, or 100-299 μg/l if transferrin saturation (T-sat) was &lt; 20%. In light of new findings, the definition of ID has been simplified in the Update ESC Guidelines for the Diagnosis and Treatment of HF to T-sat &lt; 20% or ferritin &lt; 100 μg/l.

Název v anglickém jazyce

Iron deficiency markers in patients with advanced heart failure

Popis výsledku anglicky

Introduction: Iron deficiency (ID) is a common comorbidity in patients with advanced heart failure (HF). It is associated with decreased performance status, frequent hospitalizations for HF decompensation, and lower quality of life. There is an ongoing debate about the optimal definition of ID and the selection of patients benefiting from iron supplementation. Previously, ID in HF was defined as ferritin &lt; 100 μg/l, or 100-299 μg/l if transferrin saturation (T-sat) was &lt; 20%. In light of new findings, the definition of ID has been simplified in the Update ESC Guidelines for the Diagnosis and Treatment of HF to T-sat &lt; 20% or ferritin &lt; 100 μg/l.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30200 - Clinical medicine

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů